You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fuchs' Endothelial Dystrophy

Showing 1 - 25 of 4,083
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fuchs' Endothelial Dystrophy, Cataract Trial in Singapore (Ripasudil, Placebo)

Recruiting
  • Fuchs' Endothelial Dystrophy
  • Cataract
  • Singapore, Singapore
    Singapore National Eye Centre
Sep 15, 2023

Fuchs, Fuchs Dystrophy, Fuchs' Endothelial Dystrophy Trial in United States (Ripasudil, Placebo)

Recruiting
  • Fuchs
  • +2 more
  • Palo Alto, California
  • +3 more
Jan 30, 2023

Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure Trial (Fluorometholone 0.1% Oph Susp,

Not yet recruiting
  • Pseudophakic Bullous Keratopathy
  • +2 more
  • Fluorometholone 0.1% Oph Susp
  • +2 more
  • (no location specified)
Feb 7, 2023

Fuchs Endothelial Corneal Dystrophy Trial (Ripasudil, Placebo)

Not yet recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • (no location specified)
Apr 21, 2023

Fuchs' Endothelial Dystrophy Trial in Freiburg (Supine positioning: 5 days, Supine positioning: 1 days)

Not yet recruiting
  • Fuchs' Endothelial Dystrophy
  • Supine positioning: 5 days
  • Supine positioning: 1 days
  • Freiburg, Baden-Wuerttemberg, Germany
    Medical Center - University of Freiburg, Eye Hospital
May 31, 2022

Fuchs Endothelial Corneal Dystrophy Trial in Kansas City, Portland (Ripasudil, Placebo)

Recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • Kansas City, Missouri
  • +1 more
Apr 5, 2023

Fuchs' Endothelial Dystrophy Trial in Boston (Netarsudil Ophthalmic)

Recruiting
  • Fuchs' Endothelial Dystrophy
  • Netarsudil Ophthalmic
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Aug 23, 2022

Corneal Edema, Corneal Endothelial Dystrophy, Endothelial Dysfunction Trial in Mexico City (EO2002, Ripasudil)

Recruiting
  • Corneal Edema
  • +7 more
  • Mexico City, Cdmx, Mexico
    Asociacion para Evitar la Ceguera en Mexico
Dec 1, 2022

Corneal Endothelial Decompensation, Fuchs' Endothelial Dystrophy Trial in Indianapolis, Grand Rapids (Descemet membrane

Recruiting
  • Corneal Endothelial Decompensation
  • Fuchs' Endothelial Dystrophy
  • Descemet membrane endothelial keratoplasty
  • Indianapolis, Indiana
  • +1 more
Oct 3, 2022

Fuchs Dystrophy, Cataract Trial in Town And Country (BSS Plus, BSS)

Recruiting
  • Fuchs Dystrophy
  • Cataract
  • Town And Country, Missouri
    St. Louis Eye Institute
May 11, 2023

Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen

Recruiting
  • Fuchs Dystrophy
    • Buffalo, New York
      The Ira G. Ross Eye Institute
    Apr 1, 2022

    Fuchs' Endothelial Dystrophy Trial in Vienna (Ultrahigh resolution Spectral Domain OCT)

    Completed
    • Fuchs' Endothelial Dystrophy
    • Ultrahigh resolution Spectral Domain OCT
    • Vienna, Austria
    • +1 more
    Apr 6, 2022

    Corneal Edema, Corneal Endothelial Disorder, Fuchs' Endothelial Dystrophy Trial (DSAEK, DMEK)

    Not yet recruiting
    • Corneal Edema
    • +4 more
    • DSAEK
    • DMEK
    • (no location specified)
    Jun 29, 2022

    Fuchs Endothelial Corneal Dystrophy Trial in Indianapolis, Houston (STN1010904 ophthalmic suspension 0.03% BID, STN1010904

    Recruiting
    • Fuchs Endothelial Corneal Dystrophy
    • STN1010904 ophthalmic suspension 0.03% BID
    • +2 more
    • Indianapolis, Indiana
    • +7 more
    Jan 31, 2023

    Test Diagnostic Potential of Brillouin Microscopy for Corneal

    Recruiting
    • Keratoconus
    • +3 more
    • Brillouin imaging
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 30, 2022

    Fuchs Endothelial Corneal Dystrophy, FECD3, Corneal Diseases Trial in London (QR-504a)

    Withdrawn
    • Fuchs Endothelial Corneal Dystrophy
    • +4 more
    • London, United Kingdom
      Moorfields Eye Hospital, NIHR Clinical Research Facility
    May 5, 2022

    OCT in Fuchs' Dystrophy

    Recruiting
    • Fuchs Dystrophy
    • Pseudophakic Bullous Keratopathy
      • Portland, Oregon
        Oregon Health & Science University
      Sep 21, 2021

      Fuchs' Corneal Endothelial Dystrophy in France.

      Completed
      • Fuchs Endothelial Corneal Dystrophy
      • Collection of datas
      • +2 more
      • Saint-Étienne, France
        Chu Saint-Etienne
      Dec 29, 2021

      Fuchs Endothelial Dystrophy Trial in Indianapolis (Netarsudil Ophthalmic Solution, Placebo)

      Completed
      Has Results
      • Fuchs Endothelial Dystrophy
      • Netarsudil Ophthalmic Solution
      • Placebo
      • Indianapolis, Indiana
        Price Vision Group
      Sep 23, 2021

      Fuchs' Corneal Endothelial Dystrophy in France

      Not yet recruiting
      • Corneal Dystrophies
      • Genotyping
      • +2 more
      • Saint-Étienne, France
        Centre Hospitalier de Saint-Etienne
      Feb 22, 2023

      Fuchs' Endothelial Dystrophy Trial in Indianapolis (Netarsudil, Placebo)

      Terminated
      • Fuchs' Endothelial Dystrophy
      • Indianapolis, Indiana
        Price Vision Group
      Aug 28, 2021

      Fuchs Endothelial Dystrophy Trial in Portland (Glanatec, Optive, Ophthalmic Solution, Descemet Membrane Endothelial

      Recruiting
      • Fuchs Endothelial Dystrophy
      • Portland, Oregon
        Devers Eye Institute
      Sep 2, 2021

      Fuchs' Endothelial Dystrophy Trial in Glenview (Ripasudil HCl hydrate 0.4% ophthalmic solution)

      Recruiting
      • Fuchs' Endothelial Dystrophy
      • Ripasudil hydrochloride hydrate 0.4% ophthalmic solution
      • Glenview, Illinois
        NorthShore University HealthSystem
      Aug 9, 2021

      DISCOVER Study: Microscope-integrated Intraoperative OCT Study

      Recruiting
      • Retinal Diseases
      • +4 more
        • Cleveland, Ohio
          Cole Eye Institute, Cleveland Clinic
        Mar 7, 2022

        Descemet Membrane Endothelial Keratoplasty vs. Descemet's

        Recruiting
        • Cystoid Macular Edema
        • Fuchs Dystrophy
        • Optical Coherence Tomography
        • Winston-Salem, North Carolina
          Wake Forest Health Sciences
        Dec 16, 2021